|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 18.43 USD | +0.05% |
|
+0.22% | +1.10% |
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 07-09 | Simulations Plus Fiscal Q3 Adjusted Earnings Decline, Revenue Rises | MT |
Company Valuation: Simulations Plus, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: August | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 891.9 | 1,215 | 886.5 | 725.3 | 285.2 | 372.7 | - | - |
| Change | - | 36.24% | -27.04% | -18.19% | -60.68% | 30.7% | - | - |
| Enterprise Value (EV) | 891.9 | 1,215 | 886.5 | 725.3 | 285.2 | 372.7 | 372.7 | 372.7 |
| Change | - | 36.24% | -27.04% | -18.19% | -60.68% | 30.7% | 0% | 0% |
| P/E | 94.3x | 100x | 90.8x | 74x | -4.4x | 43.9x | 40.3x | - |
| PBR | - | 6.83x | - | - | - | - | - | - |
| PEG | - | 3.6x | -5x | - | 0x | -0x | 4.51x | - |
| Capitalization / Revenue | 19.2x | 22.5x | 14.9x | 10.4x | 3.6x | 4.55x | 4.32x | 3.86x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 4.55x | 4.32x | 3.86x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 15.9x | 14.9x | - |
| EV / EBIT | 0x | 0x | 0x | 0x | -0x | 31.8x | 31.6x | 23.4x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 42.9x | 46.9x | 28.6x |
| FCF Yield | 1.97% | 1.41% | 2.41% | 1.76% | 5.18% | 2.33% | 2.13% | 3.49% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.47 | 0.6 | 0.49 | 0.49 | -3.22 | 0.42 | 0.4575 | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 46.47 | 53.91 | 59.58 | 70.01 | 79.18 | 81.87 | 86.26 | 96.46 |
| EBITDA 1 | 14.84 | 21 | 20.6 | 20.3 | 21.97 | 23.45 | 25.04 | - |
| EBIT 1 | 11.25 | 14.91 | 8.725 | 6.131 | -70.73 | 11.72 | 11.8 | 15.92 |
| Net income 1 | 9.782 | 12.48 | 9.961 | 9.954 | -64.72 | 9.534 | 10.18 | - |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 44.30 | 60.05 | 44.49 | 36.25 | 14.17 | 18.43 | 18.43 | 18.43 |
| Nbr of stocks (in thousands) | 20,133 | 20,236 | 19,927 | 20,008 | 20,127 | 20,225 | - | - |
| Announcement Date | 10/25/21 | 10/26/22 | 10/25/23 | 10/23/24 | 12/1/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 43.88x | - | - | - | 373M | |
| 42.12x | 10.16x | 22.39x | -.--% | 44.54B | |
| 97.03x | 52.79x | 67.03x | 0.54% | 13.1B | |
| 75.23x | 12.87x | 51.87x | 0.55% | 5.85B | |
| -58.05x | 16.45x | -107.72x | - | 4.25B | |
| -7.03x | 62.88x | -7.13x | - | 2.1B | |
| 34.95x | - | - | -.--% | 1.57B | |
| -129.52x | - | - | - | 1.1B | |
| 6.94x | - | - | - | 1.02B | |
| Average | 11.73x | 31.03x | 5.29x | 0.27% | 8.21B | |
| Weighted average by Cap. | 44.13x | 20.35x | 24.42x | 0.16% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SLP Stock
- Valuation Simulations Plus, Inc.
Select your edition
All financial news and data tailored to specific country editions
